No Controversy Here
While controversy exists in the USA concerning research with embryonic stem cells, everyone agrees that using adult stem cells are appropriate and efficacious. Rabin Medical Center has made a major breakthrough in applying adult stem cells to treat Parkinson's disease by developing NurOwn, a technology that generates neuron-like cells derived from human bone marrow. Using the patient's own bone marrow to supply dopamineproducing cells circumvents problems of immunity and compatibility. Credit for the discovery goes to Prof. Eldad Melamed, Director of Neurology at the Rabin Medical Center and member of the Michael J. Fox Foundation for Parkinson's Research, together with Dr. Daniel Offen, Director of Laboratory of Neurosciences at Rabin Medical Center, and Dr. Yosef Levy. Commercialized by Brainstorm Cell Therapeutics based in Tel Aviv, NurOwn actually produces the missing chemical that enables restoration of motor movement.
Related Articles
iPad Catheterization Application Used for the First Time at Rabin Medical Center
A new advanced technology has been developed for the first time worldwide, at Rabin Medical Center's Invasive Cardiology Institute, where all pertinent information collected during the cardiac catheterization procedure is sent directly to an iPad.
Israeli Hospitals Destroy Tumors With Liquid Nitrogen
IceCure Medical, an Israeli company developing a minimally invasive medical device for treating tumors, announced that it will start offering its technology in Israel in upcoming weeks.
Heart Surgeries Televised Globally
The prestigious Division of Cardiology at Rabin Medical Center, headed by Prof. Alexander Battler, is the leading facility for heart patients in Israel.